Related references
Note: Only part of the references are listed.Attenuated niacin response is associated with a subtype of first-episode drug-naive psychosis characterized as serious negative symptoms
TianHong Zhang et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2023)
How Functional Connectivity Measures Affect the Outcomes of Global Neuronal Network Characteristics in Patients with Schizophrenia Compared to Healthy Controls
Kamil Jonak et al.
BRAIN SCIENCES (2023)
A potential objective marker in first-episode schizophrenia based on abnormal niacin response
YeGang Hu et al.
SCHIZOPHRENIA RESEARCH (2022)
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce
Jerome Sarris et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2022)
Attenuated niacin-induced skin flush response in individuals with clinical high risk for psychosis
Ranpiao Gan et al.
GENERAL PSYCHIATRY (2022)
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis
Alison McLaverty et al.
EARLY INTERVENTION IN PSYCHIATRY (2021)
Kraepelin's Final Views on Dementia Praecox
Kenneth S. Kendler
SCHIZOPHRENIA BULLETIN (2021)
Dysregulation of phospholipase and cyclooxygenase expression is involved in Schizophrenia
Xuhan Yang et al.
EBIOMEDICINE (2021)
Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker
Dan-Dan Wang et al.
SCHIZOPHRENIA RESEARCH (2021)
A Systematic Review of Effectiveness of Omega-3 Fatty Acid Supplementation on Symptoms, Social Functions, and Neurobiological Variables in Schizophrenia
Mei-Chi Hsu et al.
BIOLOGICAL RESEARCH FOR NURSING (2021)
Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?
Ariel Frajerman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study
Hannah J. Jones et al.
LANCET PSYCHIATRY (2021)
Diet and Psychosis: A Scoping Review
Monique Aucoin et al.
NEUROPSYCHOBIOLOGY (2020)
O3.4. PSYCHOSIS PHENOTYPES FROM B-SNIP FOR CLINICAL ADVANCES: BIOTYPE CHARACTERISTICS AND TARGETS
Brett Clementz et al.
SCHIZOPHRENIA BULLETIN (2020)
Recent trends in mental illness and omega-3 fatty acids
Ken Yonezawa et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
SKINREMS-A New Method for Assessment of the Niacin Skin Flush Test Response in Schizophrenia
Hanna Karakula-Juchnowicz et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms
Mei-Chi Hsu et al.
LIPIDS IN HEALTH AND DISEASE (2020)
A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone
Delbert G. Robinson et al.
SCHIZOPHRENIA RESEARCH (2019)
Abnormalities in hubs location and nodes centrality predict cognitive slowing and increased performance variability in first-episode schizophrenia patients
Pawel Krukow et al.
SCIENTIFIC REPORTS (2019)
The niacin response biomarker as a schizophrenia endophenotype: A status update
Erik Messamore
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2018)
Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population
Liya Sun et al.
SCHIZOPHRENIA BULLETIN (2018)
State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study
Kerstin Langbein et al.
SCHIZOPHRENIA RESEARCH (2018)
Three Approaches to Understanding and Classifying Mental Disorder: ICD-11, DSM-5, and the National Institute of Mental Health's Research Domain Criteria (RDoC)
Lee Anna Clark et al.
PSYCHOLOGICAL SCIENCE IN THE PUBLIC INTEREST (2017)
Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia
Jeffrey K. Yao et al.
SCHIZOPHRENIA BULLETIN (2016)
Biotypes in Psychosis: Has the RDoC Era Arrived?
Daniel C. Javitt
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Biomarkers for drug development in early psychosis: Current issues and promising directions
Donald C. Goff et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis
Gregor E. Berger et al.
PLOS ONE (2016)
Cognition and autonomic function in schizophrenia: Inferior cognitive test performance in electrodermal and niacin skin flush non-responders
B. M. Nilsson et al.
EUROPEAN PSYCHIATRY (2015)
Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients
S. Nadalin et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2015)
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
S. Smesny et al.
MOLECULAR PSYCHIATRY (2014)
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
S. G. Fillman et al.
TRANSLATIONAL PSYCHIATRY (2014)
Cultures for mental health care of young people: an Australian blueprint for reform
Patrick D. McGorry et al.
LANCET PSYCHIATRY (2014)
The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients
Sergej Nadalin et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2013)
A Genome-wide Quantitative Linkage Scan of Niacin Skin Flush Response in Families With Schizophrenia
Yin-Ju Lien et al.
SCHIZOPHRENIA BULLETIN (2013)
The Ultra High Risk Approach to Define Psychosis Risk
Alison R. Yung et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Essential Fatty Acids: The Work of George and Mildred Burr
William Smith
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Niacin subsensitivity is associated with functional impairment in schizophrenia
Erik Messamore
SCHIZOPHRENIA RESEARCH (2012)
Neuroimaging and Treatment Evidence for Clinical Staging in Psychotic Disorders: From the At-Risk Mental State to Chronic Schizophrenia
Stephen J. Wood et al.
BIOLOGICAL PSYCHIATRY (2011)
Schizophrenia, Just the Facts 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse
Matcheri S. Keshavan et al.
SCHIZOPHRENIA RESEARCH (2011)
Docosahexaenoic Acid (DHA): An Ancient Nutrient for the Modern Human Brain
Joanne Bradbury
NUTRIENTS (2011)
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial
G. Paul Amminger et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
被撤回的出版物: Clinical Staging: A Heuristic and Practical Strategy for New Research and Better Health and Social Outcomes for Psychotic and Related Mood Disorders (Retracted article. See vol. 40, pg. 346, 2022)
Patrick D. McGorry et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2010)
A Hot Topic in Dyslipidemia Management-How to Beat a Flush: Optimizing Niacin Tolerability to Promote Long-term Treatment Adherence and Coronary Disease Prevention
Terry A. Jacobson
MAYO CLINIC PROCEEDINGS (2010)
Genetics and intermediate phenotypes of the schizophrenia bipolar disorder boundary
Elena I. Ivleva et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids
Rebecca Wall et al.
NUTRITION REVIEWS (2010)
The Maudsley Family Study of Psychosis - A Quest For Intermediate Phenotypes
Emmeline Goodby
PSYCHOLOGICAL MEDICINE (2010)
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study
Paul Lichtenstein et al.
LANCET (2009)
α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans
J. Thomas Brenna et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2009)
Impaired Flush Response to Niacin Skin Patch Among Schizophrenia Patients and Their Nonpsychotic Relatives: The Effect of Genetic Loading
Shu-Sen Chang et al.
SCHIZOPHRENIA BULLETIN (2009)
Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders
Elie Cheniaux et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
BASIC SYMPTOMS AND UHR CRITERIA IN THE PREDICTION OF FIRST-EPISODE PSYCHOSIS
Frauke Schultze-Lutter et al.
SCHIZOPHRENIA RESEARCH (2008)
Neurophysiological endophenotypes across bipolar and schizophrenia psychosis
Gunvant K. Thaker
SCHIZOPHRENIA BULLETIN (2008)
Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia
Stefan Smesny et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Absent response to niacin skin patch is specific to schizophrenia and independent of smoking
Chih-Min Liu et al.
PSYCHIATRY RESEARCH (2007)
Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives
Sheng-Hsiang Lin et al.
SCHIZOPHRENIA BULLETIN (2007)
Niacin skin flushing in schizophrenic and depressed patients and healthy controls
Linda Bosveld-van Haandel et al.
PSYCHIATRY RESEARCH (2006)
Niacin skin-flush response and with schizophrenia electrodermal activity in patients and healthy controls
B. M. Nilsson et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia
S Smesny et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia
S Smesny et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema
J Covault et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry
BM Ross et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
The niacin skin flush abnormality in schizophrenia: a quantitative dose - response study
E Messamore et al.
SCHIZOPHRENIA RESEARCH (2003)
Increased phospholipase A2 activity in schizophrenia with absent response to niacin
H Tavares et al.
SCHIZOPHRENIA RESEARCH (2003)
Potential use of the topical niacin skin test in early psychosis - a combined approach using optical reflection spectroscopy and a descriptive rating scale
S Smesny et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2003)
A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia
BK Puri et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Main risk factors for schizophrenia:: increased familial loading and pre- and peri-natal complications antagonize the protective effect of oestrogen in women
R Könnecke et al.
SCHIZOPHRENIA RESEARCH (2000)
Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex
K Niwa et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
